Learn more about the latest advances in gastrointestinal malignancies from ASCO GI 2022 with VJOncology!
VJOncology were delighted to attend the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium where we caught up with speakers to get their perspectives on the most exciting updates from the hybrid meeting.
See our top editorial picks below, and more at VJOncology.com
Richard Kim HIMALAYA: durvalumab/tremelimumab improves OS in HCC Dr Kim discusses highly the highly anticipated results of HIMALAYA which may represent a new standard of care for advanced HCC
Afsaneh Barzi Regorafenib + pembro for MSS-CRC Prior RT may enhance treatment outcomes of regorafenib + pembrolizumab in MSS-CRC
David S. HongSURPASS-2: SPEAR T-cell therapy Dr Hong outlines the SURPASS-2 trial of ADP-A2M4CD8 in pts with HLA-A2-positive esophageal or GEJ cancers expressing MAGE-A4
Justin Mencel PREVAIL: ctDNA for the diagnosis of pancreatic & biliary tract cancer ctDNA may be used reliably for diagnosis in patients who are unable to undergo biopsies or for difficult to access tumors.
GI Cancer Sessions Watch the latest GI Cancer Session!
Listen to Lizzy Smyth, Yelena Janjigian, and Zev Wainberg, who offer their perspectives on the key data and highlights in upper gastrointestinal cancer from the ESMO 2021 Annual Meeting.
Check out our disease channels!
Check out more developments across different disease types with our dedicated disease channels, featuring expert interviews, podcasts, roundtable discussions and more
Don't miss out on our VJSessions, expert-led roundtable discussions!
GU Cancer Sessions Join Elizabeth Plimack, Rana McKay & Thomas Powles as they discuss the latest learnings in bladder and kidney cancer from ASCO 2021
Lung Cancer Sessions Melissa Johnson, Heather Wakelee & Lizza Hendriks discuss the latest developments in the field of lung cancer presented at ASCO 2021.
